• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性多发性硬化症是否与更差的预后相关?

Is late-onset multiple sclerosis associated with a worse outcome?

作者信息

Tremlett Helen, Devonshire Virginia

机构信息

Department of Medicine (Neurology), Rm. S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver, BC V6T 2B5, Canada.

出版信息

Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d.

DOI:10.1212/01.wnl.0000237475.01655.9d
PMID:17000960
Abstract

OBJECTIVE

To describe the characteristics of late-onset multiple sclerosis (MS) (LOMS, 50+ years) vs adult-onset MS (AOMS, 16 to <50 years) and examine prognosis and associated risk factors.

METHODS

Patients with definite MS, onset prior to July 1988, registered with a BCMS clinic before July 1998, with at least one Expanded Disability Status Scale (EDSS) score, were selected from the longitudinal population-based British Columbian (BC) MS database. Clinical and demographic characteristics were compared between LO and AOMS. Progression was measured as time to reach sustained EDSS 6 and potential risk factors examined were sex, disease course (primary progressive [PP] vs relapsing [R]), and onset symptoms.

RESULTS

Of those eligible (n = 2,837), LOMS comprised 132 (4.7%), with PPMS predominating (54.5% vs 10.6% in AOMS, p < 0.0005). Motor onset symptoms were more prevalent in LOMS and sensory and optic neuropathy more prevalent in AOMS (p < 0.0005). AOMS averaged 27.7 years (95% CI: 26.3 to 29.1) to EDSS 6 from onset vs 16.9 years (95% CI: 9.0 to 24.8) in LOMS, p < 0.0005. However, AOMS was associated with a younger age at EDSS 6 (58.4 years [95% CI: 57.1 to 59.6] vs 71.2 years [95% CI: 65.2 to 77.3] in LOMS, p < 0.0005). There were no differences in progression between AO or LO for those with PPMS (p = 0.373) or R-MS (p = 0.438), although considerable variation was observed.

CONCLUSIONS

Late-onset multiple sclerosis (LOMS) is not necessarily associated with a worse outcome: first, progression in the primary progressive or relapsing patients differed little between late-onset vs adult-onset; secondly, those with LOMS were older when reaching Expanded Disability Status Scale 6. The disease course has a far greater implication for disease prognosis than the presence of LOMS.

摘要

目的

描述晚发型多发性硬化症(LOMS,年龄≥50岁)与成人发病型多发性硬化症(AOMS,年龄16至<50岁)的特征,并研究其预后及相关危险因素。

方法

从基于人群的纵向不列颠哥伦比亚省(BC)多发性硬化症数据库中,选取1988年7月前发病、1998年7月前在BCMS诊所登记且至少有一次扩展残疾状态量表(EDSS)评分的确诊多发性硬化症患者。比较LOMS和AOMS的临床及人口统计学特征。以达到持续EDSS 6的时间衡量疾病进展,研究的潜在危险因素包括性别、病程(原发进展型[PP]与复发型[R])及起病症状。

结果

在符合条件的2837例患者中,LOMS有132例(4.7%),以原发进展型多发性硬化症(PPMS)为主(54.5%,而AOMS中为10.6%,p<0.0005)。运动起病症状在LOMS中更常见,感觉和视神经病变在AOMS中更常见(p<0.0005)。AOMS从发病到EDSS 6平均需要27.7年(95%CI:26.3至29.1),而LOMS为16.9年(95%CI:9.0至24.8),p<0.0005。然而,达到EDSS 6时AOMS患者年龄较轻(58.4岁[95%CI:57.1至59.6],而LOMS为71.2岁[95%CI:65.2至77.3],p<0.0005)。对于PPMS患者(p = 0.373)或复发缓解型多发性硬化症(R-MS)患者(p = 0.438),成人发病型与晚发型在疾病进展方面无差异,尽管存在相当大的变异性。

结论

晚发型多发性硬化症(LOMS)不一定预后更差:其一,原发进展型或复发型患者中,晚发型与成人发病型在疾病进展方面差异不大;其二,达到扩展残疾状态量表6时,LOMS患者年龄更大。病程对疾病预后的影响远大于晚发型的存在。

相似文献

1
Is late-onset multiple sclerosis associated with a worse outcome?迟发性多发性硬化症是否与更差的预后相关?
Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d.
2
Natural history of secondary-progressive multiple sclerosis.继发进展型多发性硬化的自然史。
Mult Scler. 2008 Apr;14(3):314-24. doi: 10.1177/1352458507084264. Epub 2008 Jan 21.
3
Disability progression in multiple sclerosis is slower than previously reported.多发性硬化症的残疾进展比先前报道的要慢。
Neurology. 2006 Jan 24;66(2):172-7. doi: 10.1212/01.wnl.0000194259.90286.fe.
4
Effect of gender on late-onset multiple sclerosis.性别对迟发性多发性硬化症的影响。
Mult Scler. 2012 Oct;18(10):1472-9. doi: 10.1177/1352458512438236. Epub 2012 Mar 1.
5
The natural history of primary progressive multiple sclerosis.原发性进行性多发性硬化症的自然病史。
Neurology. 2009 Dec 8;73(23):1996-2002. doi: 10.1212/WNL.0b013e3181c5b47f.
6
The natural history of primary progressive MS in British Columbia, Canada.加拿大不列颠哥伦比亚省原发性进行性多发性硬化症的自然病史。
Neurology. 2005 Dec 27;65(12):1919-23. doi: 10.1212/01.wnl.0000188880.17038.1d.
7
Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.多发性硬化症发病年龄较大是预后不良的独立因素:一项基于人群的队列研究。
Neuroepidemiology. 2017;48(3-4):179-187. doi: 10.1159/000479516. Epub 2017 Aug 10.
8
Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.约旦人群中早发型和成年型多发性硬化症的自然病史及预后特征比较。
Clin Neurol Neurosurg. 2007 Jan;109(1):32-7. doi: 10.1016/j.clineuro.2006.06.002. Epub 2006 Jul 25.
9
Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.西澳大利亚迟发性多发性硬化的临床特征和 HLA-DRB1 基因型。
J Clin Neurosci. 2010 Aug;17(8):1009-13. doi: 10.1016/j.jocn.2009.12.011. Epub 2010 May 23.
10
Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.与加拿大两个多发性硬化症队列中医疗识别延迟相关的因素。
J Neurol Sci. 2010 May 15;292(1-2):57-62. doi: 10.1016/j.jns.2010.02.007. Epub 2010 Mar 4.

引用本文的文献

1
Response to therapy in a cohort of patients with late-onset multiple sclerosis.一组迟发性多发性硬化症患者的治疗反应
Mult Scler J Exp Transl Clin. 2025 Jul 29;11(3):20552173251360357. doi: 10.1177/20552173251360357. eCollection 2025 Jul-Sep.
2
Multiple Sclerosis After the Age of 50 Years: A Comparative Analysis of Late Onset and Adult Onset.50岁之后的多发性硬化症:迟发性与成人发病型的比较分析
J Clin Neurol. 2025 May;21(3):201-212. doi: 10.3988/jcn.2024.0302.
3
Impaired remyelination in late-onset multiple sclerosis.迟发性多发性硬化症中髓鞘再生受损。
Acta Neuropathol. 2025 Apr 1;149(1):30. doi: 10.1007/s00401-025-02868-5.
4
Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy.儿童、成人和迟发性多发性硬化症:认知表型与灰质萎缩
Ann Clin Transl Neurol. 2025 Mar;12(3):512-522. doi: 10.1002/acn3.52291. Epub 2025 Jan 24.
5
Management of multiple sclerosis in older adults: review of current evidence and future perspectives.老年人多发性硬化症的管理:当前证据的回顾与未来展望。
J Neurol. 2024 Jul;271(7):3794-3805. doi: 10.1007/s00415-024-12384-3. Epub 2024 Apr 30.
6
Challenges in Diagnosis and Therapeutic Strategies in Late-Onset Multiple Sclerosis.迟发性多发性硬化症的诊断挑战与治疗策略
J Pers Med. 2024 Apr 10;14(4):400. doi: 10.3390/jpm14040400.
7
Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.迟发性多发性硬化的临床特征和长期预后:一项瑞典全国性研究。
Neurology. 2024 Mar 26;102(6):e208051. doi: 10.1212/WNL.0000000000208051. Epub 2024 Feb 23.
8
Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.迟发性多发性硬化症:意大利多发性硬化症注册研究中复发缓解型患者的残疾轨迹。
J Neurol. 2024 Apr;271(4):1630-1637. doi: 10.1007/s00415-023-12152-9. Epub 2024 Jan 3.
9
Clinical and Epidemiological Aspects of Late Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-Based Study.伊朗东阿塞拜疆省迟发性多发性硬化的临床和流行病学特征:一项基于人群的研究。
Arch Iran Med. 2022 Nov 1;25(11):725-729. doi: 10.34172/aim.2022.114.
10
Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases - a retrospective cross-sectional study.老年非多发性硬化慢性自身免疫性炎症性神经系统疾病患者鞘内多特异性免疫反应的临床关联及特征——一项回顾性横断面研究
Front Neurol. 2023 Jun 15;14:1193015. doi: 10.3389/fneur.2023.1193015. eCollection 2023.